| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Anastrozole | FAERS: 1 | US FAERS | |
| 2 | Gefitinib | FAERS: 1 | US FAERS | |
| 3 | MDV 3100 | FAERS: 1 | US FAERS | |
| 4 | Olanzapine | FAERS: 1 | US FAERS | |
| 5 | Teriparatide | FAERS: 1 | US FAERS | |
| 6 | Thyroxine | FAERS: 1 | US FAERS | |
| 7 | gemcitabine | FAERS: 1 | US FAERS | |
| 8 | tavaborole | FAERS: 1 | US FAERS | |
| 9 | teriflunomide | FAERS: 1 | US FAERS | |
| 10 | tofacitinib | FAERS: 1 | US FAERS | |
| 11 | Paclitaxel | SIDER | ||
| 12 | Pamidronate | OFFSIDES | ||
| 13 | Terbinafine | Canada Vigilance: 1 | Canada Vigilance | |
| 14 | strontium ranelate | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.